Catalyst Pharmaceutical Partners, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
19.90
|
|
Average Rating
|
4.20
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.19
|
0.20
|
0.01
|
5.26%
|
|
2022-06-30
|
0.17
|
0.20
|
0.03
|
17.65%
|
|
2022-03-31
|
0.14
|
0.12
|
-0.02
|
-14.29%
|
|
2021-12-31
|
0.12
|
0.09
|
-0.03
|
-25.00%
|
|
2021-09-30
|
0.10
|
0.10
|
0.00
|
0.00%
|
|
2021-06-30
|
0.10
|
0.11
|
0.01
|
10.00%
|
|
2021-03-31
|
0.09
|
0.07
|
-0.02
|
-22.22%
|
|
2020-12-31
|
0.09
|
0.11
|
0.02
|
22.22%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.52
|
|
2021-12-31
|
0.37
|
|
2020-12-31
|
0.71
|
|
2019-12-31
|
0.30
|
|
2018-12-31
|
-0.34
|
|
2017-12-31
|
-0.22
|
|
2016-12-31
|
-0.23
|
|
2015-12-31
|
-0.25
|
|
2014-12-31
|
-0.24
|
|
2013-12-31
|
-0.61
|
|
2010-12-31
|
-0.22
|
|
2009-12-31
|
-0.50
|
|
2008-12-31
|
-0.81
|
|
2007-12-31
|
-0.58
|